Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States
Authors:
- 17 March 2022
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (3) , 670-680.e18
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine TransaminaseCancer Epidemiology, Biomarkers & Prevention, 2017
- Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosisAlimentary Pharmacology & Therapeutics, 2016
- Cirrhosis is under‐recognised in patients subsequently diagnosed with hepatocellular cancerAlimentary Pharmacology & Therapeutics, 2016
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective studyHepatology, 2016
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009Hepatology, 2015
- An MLP Classifier for Prediction of HBV-Induced Liver Cirrhosis Using Routinely Available Clinical ParametersDisease Markers, 2013
- Failure Rates in the Hepatocellular Carcinoma Surveillance ProcessCancer Prevention Research, 2012
- The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databasesAlimentary Pharmacology & Therapeutics, 2007
- Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.2002
- Overview of the SEER-Medicare DataMedical Care, 2002